Why this trial matters: Provides real-world evidence on first-line regimens in a poor-prognosis mCRC subtype Highlights superior survival with chemo + anti-VEGF versus chemo alone or targeted therapy Reinforces the importance of personalized treatment strategies and further trials Eli Lilly Retatrutide Delivers Unprecedented Weight Loss in Phase III TRIUMPH-4 Trial Eli Lillys investigational triple-agonist retatrutide produced an average ~28.7% body-weight reduction (71.2 lbs) at 68 weeks in the Phase III TRIUMPH-4 obesity trial, along with meaningful knee osteoarthritis pain relief, marking one of the strongest weight-loss results reported in late-stage obesity research
Moreover, our team has described recently that in normoxia and in glucose free media ES2 has higher levels of thiols than OVCAR3 23
During the Inca Trail, do not forget to take with you: Passport
During the treatment phase, cell death was observed and quantified using STACK as previously described (Forcina et al, 2017)
Iron overload has been found to play a pathogenic role in cardio-cerebrovascular toxicity both in animal models and in patients with different CCVDs
Sulfur-containing Cruciferous Vegetables Cruciferous vegetables like Broccoli, Brussels sprouts, cauliflower and kale are known to help boost glutathione levels because they are rich in sulfur
